CervoMed Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was USD 2.17 million compared to USD 5.8 million a year ago. Basic loss per share from continuing operations was USD 0.82 compared to USD 11.2 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.69 USD | -1.27% | -5.32% | +144.95% |
20/05 | CervoMed Names William Elder CFO | MT |
15/05 | Earnings Flash (CRVO) CERVOMED Posts Q1 Revenue $2.3M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+144.95% | 154M | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-0.38% | 22.1B | |
-9.28% | 18.34B | |
-41.70% | 16.59B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- CRVO Stock
- News CervoMed Inc.
- CervoMed Inc. Reports Earnings Results for the Full Year Ended December 31, 2023